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Abstract
Background: The impact of the presence and awareness of individual health states on quality of life (HRQoL) is often
documented. However, the impacts of different health states have rarely been compared amongst each other, whilst quality
of life data from Asia are relatively sparse. We examined and compared the effects of different health states on quality of life
in a Thai population.
Methods: In 2008–2009, 5,915 corporate employees were invited to participate in a survey where HRQoL was measured by
the Short Form 36 (SF-36) questionnaire. The adjusted mean SF-36 scores were calculated for each self-reported illness,
number of chronic conditions, lifestyle factors and awareness of diabetes and hypertension. The effect sizes (ES) were
compared using Cohen’s d.
Results: The response rate was 82% and 4,683 (79.1%) had complete data available for analysis. Physical and Mental
Component Summary (PCS and MCS) scores decreased as the number of chronic conditions increased monotonically
(p,0.0001). Diabetes and hypertension negatively influenced PCS (mean score differences 20.6 and 21.5, p,0.001
respectively) but not MCS, whereas awareness of diabetes and hypertension negatively influenced MCS (22.9 and 21.6,
p,0.005 respectively) but not PCS. Arthritis had the largest ES on PCS (20.37), while awareness of diabetes had the largest
ES on MCS (20.36). CVD moderately affected PCS and MCS (ES20.34 and 20.27 respectively). Obesity had a negative effect
on PCS (ES 20.27). Exercise positively affected PCS and MCS (ES +0.08 and +0.21 (p,0.01) respectively).
Conclusion: Health promotion to reduce the prevalence of chronic diseases is important to improve the quality of life in
Asian populations. Physical activity is an important part of such programs. Awareness of diseases may have greater impacts
on mental health than having the disease itself. This has implications for the evaluation of the cost-benefit of screening and
labeling of individuals with pre-disease states.
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Health-Related Quality of Life (HRQoL) refers to the physical,
emotional, and social impact of disease and treatments and is
distinct from physiologic measures of disease. Increasingly, this
measure has been used in clinical studies of patients with chronic
conditions [1]. Studies have shown that living with a chronic
condition significantly reduces HRQoL [2–10], and having
multiple chronic conditions reduces HRQoL even further [11–
13].
Hypertension and diabetes are two common conditions that are
responsible for a considerable burden of chronic illness and death.
In recent times, both have had new extended definitions to include
so-called pre-hypertension and pre-diabetes states. But, at least for
hypertension, those aware of their hypertension have been found
to have a lower HRQoL than those unaware (i.e. there is a
‘‘labeling effect’’) [14–18]. However, the impact of awareness of
diabetes on HRQoL has been rarely explored, with two studies
reporting that screening for diabetes has no impact on HRQoL or
anxiety/depression [19,20] and a further study finding higher
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levels of short-term anxiety among those diagnosed with diabetes
compared to those who were not [21]. Moreover, HRQoL is also
affected by lifestyle factors. With many factors affecting HRQoL,
an understanding of their relative impact can assist in developing
strategies aimed at improving HRQoL.
Whilst there have been many studies from the West, few studies
have been conducted in Asia, where social norms, cultural and
religious beliefs are different and may affect a person’s perception
of HRQoL. In this report, we study HRQoL in Thailand,
examining the effects of lifestyle factors and different health states,
including hypertension and diabetes, on HRQoL and comparing
them to each other.
Methods
The Electricity Generating Authority of Thailand (EGAT) study
[22] is a longitudinal study comprising of 3 waves of recruitments,
referred to as EGAT 1, 2 and 3. Data used in this study is cross-
sectional, comprising data from the third EGAT 2 survey in 2008
and the first EGAT 3 survey in 2009: the most recent survey data,
to date. From 5,915 invitees aged 25–70 years, 4,850 (82%) agreed
to participate: 4000 working at the EGAT headquarters in
Bangkok and 850 at hydro-electric plants in remote areas.
Information was collected, through interviews by trained profes-
sionals, on age, sex, socioeconomic status (SES) and lifestyle, as
well as details of self-reported common chronic medical condi-
tions, including drug treatment. These self-reported conditions
were coronary heart disease (CHD), stroke, peripheral arterial
disease (PAD), chronic heart failure (CHF), diabetes, chronic
kidney disease (CKD), liver disease, asthma, arthritis and
rheumatism, systemic lupus erythematosus (SLE), Parkinson’s
disease, and epilepsy. CVD was defined as any of CHD, stroke,
PAD and CHF.
HRQoL was measured using a bilingual version of the Short
Form 36 (SF-36) version 2 questionnaire, which has been shown to
be reliable and valid in Thailand [23]. The SF-36 measures eight
domains (dimensions) of health status: physical functioning (PF),
role-physical (RP), bodily pain (BP), general health (GH), vitality
(VT), social functioning (SF), role-emotional (RE) and mental
health (MH) [24]. SF-36 domain scores were further summarized
into a physical component summary (PCS) score and a mental
component summary (MCS) score. All scores range from zero
(worst health) to 100 (best health), and are scaled relative to the
United States population (mean= 50, standard deviation = 10).
Body mass index (BMI) was computed as measured weight in
kilograms divided by the square of height in meters. Blood
pressure was measured twice with an automatic device in the
seated position, after five minutes rest and averaged. Hypertension
was defined as systolic blood pressure (SBP) $140 mm Hg and/or
diastolic blood pressure (DBP) $90 mm Hg, and/or self-reported
(pharmacological) treatment for hypertension within the 2 weeks
prior to the interview. Awareness of hypertension was defined as a
self-report of any prior diagnosis of hypertension by a healthcare
professional. Control of hypertension was defined as having an
average SBP ,140 mmHg and an average DBP ,90 mmHg (in
those not having diabetes and CKD) and an average SBP
,130 mmHg and an average DBP ,80 (in those with diabetes or
CKD) in the context of pharmacological treatment of hyperten-
sion [25]. Diabetes was defined as an overnight fasting blood
glucose $7.0 mmol/l and/or self-reported diabetes prior to the
survey [26]. Control of diabetes was defined as having fasting
blood glucose less than 126 mg/dl. As with hypertension,
treatment for diabetes was self-reported and restricted to
pharmacological treatment.
The Institutional Review Board at Mahidol University ap-
proved the study. Written informed consent was obtained from
each participant before data were collected.
Data analysis
Mean PCS and MCS scores were compared by age categories
(sex adjusted), sex (age adjusted), SES and lifestyle variables (age
and sex adjusted) and each self-reported chronic condition and
number of chronic conditions (age, sex and SES adjusted) using
generalized linear models (GLM) [27]. A multiple regression
model was used to test for linear trend if a variable contained more
than two categories. According to awareness, treatment and
control of hypertension and diabetes, GLMs with full adjustment
were used to evaluate the differences between no disease/disease,
unaware/aware, untreated/treated and uncontrolled/controlled.
Two sensitivity analyses were performed for awareness: (i) using
the cut-off at 140/90 mmHg to determine controlled hypertension
in all subjects (including subjects with CKD and diabetes) and (ii)
taking comorbidity into the multivariable model. The effect sizes
Table 1. Descriptive statistics for SF-36 scores (n = 4,683).
SF-36 component (and abbreviation) No. of items Range Mean (SD) Median (IQR)
Physical Functioning (PF) 10 0–100 77.3 (19.4) 80 (65–95)
Role limitations due to Physical health (RP) 4 0–100 86.7 (17.5) 94 (75–100)
Bodily Pain (BP) 2 0–100 75.1 (21.2) 74 (62–100)
General Health (GH) 5 0–100 63.2 (18.4) 65 (52–77)
Vitality (VT) 4 6.25–100 66.9 (14.8) 69 (56–75)
Social Functioning (SF) 2 12.5–100 84.4 (16.9) 88 (75–100)
Role limitations due to Mental health (RE) 3 8.3–100 87.4 (17.3) 100 (75–100)
Mental Health (MH) 5 5–100 74.6 (14.9) 75 (65–85)
Physical Component Summary (PCS) 21 8.75–100 76.1 (13.9) 78 (68–87)
Mental Component Summary (MCS) 14 22.7–100 78.3 (12.8) 80 (70–88)
Note: PF = physical functioning; RP = role physical; BP =bodily pain; GH=general health; VT = vitality; SF = social functioning; RE = role emotional; MH=mental health;
PCS = physical component score (comprises of PF+RP+BP+GH); MCS =mental component score (comprises of VT+SF+RE+MH); SD= standard deviation;
IQR = interquartile range (25th–75th percentile).
SF-36 scores range from zero (worst health) to 100 (best health) and are scaled relative to those of the United States population (mean= 50, standard deviation = 10).
doi:10.1371/journal.pone.0049921.t001
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(ES), for PCS and MCS scores, were computed from all analyses
on lifestyles, self-reported conditions and awareness, treatment and
control of diseases, using Cohen’s d [28]. The effects of those
factors studied on HRQoL were of a similar magnitude and in the
same direction for both sexes (selected results are shown in
Appendix S1, S2), and so the sexes were combined. Results
associated with a probability of #0.05 (two-tailed test) were
considered statistically significant. Statistical analyses were per-
formed using SAS version 9.2 (SAS Institute Inc., Cary, NC,
USA).
Table 2. PCS and MCS norm-based scores according to socio-demographic and lifestyle characteristics (n = 4,683).
Age and sex adjusted mean (SE)
n (%) PCS MCS
Sex Male 3390 (72%) 50.1 (0.1) 51.0 (0.1)
Female 1293 (28%) 48.3 (0.2) 50.1 (0.2)
p,0.001 p,0.001
Age Group (years) 25–34 464 (10%) 52.5 (0.3) 49.6 (0.4)
35–44 1257 (27%) 50.7 (0.2) 49.6 (0.2)
45–54 2255 (48%) 48.9 (0.1) 51.0 (0.2)
55–70 707 (15%) 47.7 (0.3) 53.0 (0.3)
p,0.001 p,0.001
Rurality Urban 3581 (76%) 49.7 (0.1) 50.6 (0.1)
Rural 1102 (24%) 49.1 (0.2) 51.2 (0.2)
p= 0.01 p= 0.04
Marital Status Married 3526 (75%) 50.1 (0.2) 51.0 (0.2)
Not married 1157 (25%) 49.4 (0.1) 50.7 (0.1)
p= 0.01 p= 0.2
Education Compulsory 602 (13%) 48.5 (0.3) 51.6 (0.3)
Vocational 1323 (28%) 48.9 (0.2) 51.0 (0.2)
Bachelor 2030 (43%) 49.9 (0.2) 50.4 (0.2)
Master/Doctorate 728 (16%) 51.0 (0.3) 50.7 (0.3)
p,0.001 p= 0.01
Income (Baht/month) ,20,000 300 (6%) 48.8 (0.4) 51.1 (0.5)
20,000–50,000 1576 (34%) 49.1 (0.2) 50.8 (0.2)
50,000–100,000 2031 (43%) 49.7 (0.2) 50.5 (0.2)
.100,000 776 (17%) 50.6 (0.2) 51.1 (0.3)
p,0.001 p= 0.9
Smoking Never smoker 2800 (62%) 49.6 (0.1) 50.9 (0.2)
Previous smoker 871 (20%) 49.6 (0.2) 50.6 (0.3)
Current smoker 819 (18%) 49.3 (0.2) 50.6 (0.3)
p= 0.2 p= 0.4
Current alcohol No 1900 (41%) 49.5 (0.2) 51.1 (0.2)
Yes 2763 (59%) 49.6 (0.1) 50.6 (0.2)
p= 0.6 p= 0.03
Exercise ,3 sessions/week 3175 (68%) 49.4 (0.1) 50.2 (0.1)
$3 sessions/week 1491 (32%) 50.0 (0.2) 51.9 (0.2)
p= 0.004 p,0.001
Obesity as measured by BMI* Underweight 167 (4%) 50.7 (0.5) 50.4 (0.6)
Normal 2717 (58%) 50.1 (0.1) 50.7 (0.2)
Overweight 1433 (31%) 49.0 (0.2) 50.8 (0.2)
Obesity 344 (7%) 48.0 (0.4) 51.3 (0.4)
p,0.001 p= 0.2
Note: PCS = physical component score; MCS=mental component score; SF-36 scores range from zero (worst health) to 100 (best health) and are scaled relative to those
of the United States population; p values for trend in variables with more than 2 categories;
*Body mass index (BMI): Underweight: ,18.5 kg/m2; Normal: 18.5–24.9 kg/m2; Overweight: 25–29.9 kg/m2; Obesity: $30 kg/m2. SE = standard error.
doi:10.1371/journal.pone.0049921.t002
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Results
Summary statistics for SF-36
Of the 4,850 participants, 4,683 (97%) had complete informa-
tion on SF-36 PCS and MCS scores and sociodemographic data,
and were included in this study. Table 1 shows descriptive statistics
of SF-36 scores for all participants. The mean PCS score was 49.6
and the MCS score was 50.8.
Sociodemographic and lifestyle associations
Men had higher PCS and MCS scores than women (50.1 versus
48.3 and 51.0 versus 50.1 respectively, p,0.001). (Table 2) Older
age and living in a rural area were associated with lower PCS but
higher MCS, whereas higher education was associated with higher
PCS but lower MCS (all p values ,0.05). Exercise was associated
with higher mean scores for both summary components (PCS 50.0
versus 49.4, p 0.008 and MCS 51.9 versus 50.2, P,0.0001).
Increasing BMI was associated with lower PCS (p for trend
,0.001) while it had no association with MCS.
Self-reported disease
Of the 12 health conditions that were assessed, 68% of
participants reported having none, 25% reported 1 condition,
5.2% reported 2 conditions and 1.2% reported 3 or more
conditions (to a maximum of 7). Chronic liver disease had the
highest prevalence in this population, at 11.4%, followed by
arthritis (10.4%), diabetes (6.7%), asthma (4.8%), CVD (3.4%) and
CKD (1.4%). When adjusted for age, sex and SES, participants
who were free from chronic conditions scored the highest HRQoL
in all dimensions, and thus on PCS and MCS. Figure 1 displays
the adjusted differences in mean SF-36 scores between those who
were free from chronic conditions (the reference group) and those
having 1, 2 or$3 chronic conditions. The differences between$3
and the reference were highest in GH (8.0) (p for trend ,0.0001).
Both PCS and MCS decreased when the number of chronic
conditions increased, starting from 50.3 and 51.7 in the group with
no chronic condition to 46.0 and 46.6 for those with $3
conditions (PCS and MCS respectively, p for trend ,0.0001).
Table 3 shows specific results for the 5 most common
conditions, excluding diabetes (see table 4 for the associations
with diabetes). All but asthma negatively affected PCS (p,0.05),
and all but CKD negatively affected MCS (p,0.05). Participants
who reported having liver disease, CVD or arthritis had
significantly lower SF-36 scores in every dimension, when
compared to those who answered no for that specific disease (all
p,0.05). Asthma was associated with reduced GH (p,0.05) while
CKD was associated with reduced BP (p,0.05). PCS was lowest in
those with arthritis and CVD (47.4 in both). MCS was lowest in
CVD (49.1). The magnitude of the impacts of different diseases on
HRQoL increased when compared to an alternative reference
group comprising those without any reported chronic condition,
rather than those without only the index disease. Percent
distribution of comorbidity within these diseases is demonstrated
in Appendix S3. Liver disease, asthma and arthritis share a similar
disease pattern in that 66–67% of them are stand-alone conditions,
followed by 25–26% with one accompanying condition and 7–8%
with more than one condition. Multiple comorbidities are likely to
be found in CVD and CKD, in that 43–46% of them have at least
one accompanying condition. A sensitivity analysis in which we
take number of comorbidity into account, gives grossly similar
effects and statistical significances in each condition.
Impact of awareness and treatment in people with
hypertension and diabetes
Table 4 explores the associations between awareness, treatment
and control of hypertension and diabetes and the SF-36 scores.
Participants who had diabetes rated their PCS lower than non-
diabetes (p,0.0001). The MCS scores were not different between
having and not having this condition (p= 0.08). However,
significant differences in MCS were found amongst those who
were aware or not aware of having diabetes. Awareness of diabetes
had a substantial negative impact on MCS (p= 0.003); conversely,
awareness of diabetes did not influence the PCS score (p = 0.2). No
difference in PCS and MCS were detected between treated and
untreated; or controlled and uncontrolled groups. The impacts of
awareness, treatment and control of hypertension on HRQoL
displayed a similar picture to diabetes. The sensitivity analyses
yielded similar effects and statistical significances in both
conditions.
Impact of disease severity in people who were aware of
their disease
Appendix S4 shows adjusted SF-36 scores, according to severity
of hypertension, diabetes, CKD and subgroups of CVD, in those
who were aware of that particular disease. No relationship
between disease severity and HRQoL was detected among
subjects with hypertension, diabetes and CKD. There are
significant differences in PCS and MCS amongst CVD subtypes.
Effect sizes
Taking all factors considered, arthritis had the largest negative
impact (ES of 20.37) on PCS, followed by CVD (20.34), obesity
(20.27), and CKD (20.27) (figure 2). Awareness of diabetes and
hypertension had smaller negative effects on PCS, compared to
having a serious medical condition. Regarding the MCS,
awareness of diabetes showed the greatest negative effect on
Figure 1. Magnitude of mean reductions in HRQoL in
participants reporting one, two and three or more conditions;
compared to subjects reporting no chronic medical condition.
Footnote: PF =physical functioning; RP = role physical; BP =bodily
pain; GH=general health; VT = vitality; SF = social functioning; RE = role
emotional; MH =mental health; PCS = physical component score
(comprises of PF+RP+BP+GH); MCS=mental component score (com-
prises of VT+SF+RE+MH); Chronic medical conditions includes 1.coro-
nary heart disease (n = 70 cases) 2.congestive heart failure (n = 10)
3.stroke (n = 57) 4.peripheral arterial disease (n = 41) 5.chronic kidney
disease (n = 65) 6.chronic liver disease (n = 532) 7.asthma (n = 224)
8.arthritis and rheumatism (n = 488) 9.diabetes mellitus (n = 315)
10.Parkinson’s disease (n = 2) 11.epilepsy (n = 34) and 12.systemic lupus
erythematosus (n = 33); Number of chronic medical conditions are
determined by summing the conditions described above. All analyses
were adjusted for age, sex, marital status, education, income and
rurality. *All analyses yielded p for trend ,0.0001.
doi:10.1371/journal.pone.0049921.g001
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MCS (20.36), followed by CVD (20.27), chronic liver disease
(20.21) and awareness of hypertension (20.20). Exercise was the
only factor to show a positive effect on both PCS (+0.08) and MCS
(+0.21). These effects were comparable in size, but in the opposite
direction, to having liver disease or diabetes. Lastly, obesity
showed a trivial positive effect on MCS (+0.08), but a large
negative effect on PCS (20.27).
Discussion
In addition to adding to the limited information on HRQoL in
Asia, there are, as far as we are aware, two novel aspects to this
study. This is the first time that the effects of multiple chronic
conditions, awareness of diseases and lifestyle factors on HRQoL
have been explicitly illustrated and made comparable to each
other. Second, this study is the first to show that awareness of
diabetes has a particularly strong impact on mental health, larger
than having CVD or chronic liver disease. Other major findings
are that exercise was the only factor considered that had a
significant beneficial effect on both physical and mental health.
Furthermore, its impact on mental health was of a sufficient
magnitude to cancel out the adverse effects of most chronic
conditions, at least in statistical terms. Obesity has a considerably
large negative impact on physical health. These latter findings are
particularly important since they involve readily modifiable
factors.
The first use of the SF-36 in Thais was in 2000, when it was
validated in Thai cardiac patients [29]. Since then the Thai
version of SF-36 has been utilized in many clinical settings
[8,30,31], as well as in a general population [23]. The relationship
between the number of chronic conditions and HRQoL found
here is consistent with other studies that found a trend towards
poorer HRQoL when comorbidity increased [11–13]. In those
having three or more conditions, four to eight point decrements in
the domain scores and the biggest and smallest drops in GH and
RE respectively, were similar here to those reported in Australia
[13]. It is plausible that the wider gap in GH and BP was due to
the selection of diseases that primarily affected physical, not
mental, well-being.
Regarding awareness of hypertension: to date, there have been
two published articles analyzing the impact of awareness of
hypertension on HRQoL in adults, using the SF-36 instrument
[14,16]. Unlike our findings, both of these studies found that
hypertension awareness predominately affected physical, rather
than mental domains of HRQoL. A population-based study from
Spain [14] reported significant reductions in PF, BP, VT and MH
Table 4. Adjusted mean (with standard error) SF-36 norm-based scores according to hypertension and diabetes, and to
awareness, drug treatment and control of hypertension and diabetes.
HYPERTENSION: Awareness, Treatment, Control PCS MCS
No disease (n = 3247) 49.5 (0.2) 51.1 (0.2)
Disease (n = 1436) 48.8 (0.2) 51.0 (0.3)
p= 0.006 p=0.6
Unaware (n = 637) 48.1 (0.4) 51.9 (0.4)
Aware (n = 799) 48.2 (0.4) 50.3 (0.4)
p= 0.9 p=0.0002
Untreated (n = 152) 48.0 (0.7) 50.5 (0.8)
Treated (n = 647) 47.3 (0.4) 50.2 (0.5)
p= 0.4 p=0.7
Uncontrolled (n = 377) 46.8 (0.6) 49.9 (0.6)
Controlled (n = 270) 47.7 (0.6) 50.4 (0.6)
p= 0.1 p=0.4
DIABETES: Awareness, Treatment, Control PCS MCS
No disease (n = 4262) 49.4 (0.2) 51.2 (0.2)
Disease (n = 420) 47.9 (0.4) 50.4 (0.4)
p,0.0001 p=0.08
Unaware (n = 104) 47.4 (1.1) 52.1 (1.1)
Aware (n = 316) 46.3 (0.8) 49.4 (0.8)
p= 0.2 p=0.003
Untreated (n = 89) 46.6 (1.2) 49.6 (1.2)
Treated (n = 227) 46.3 (0.9) 49.2 (0.9)
p= 0.8 p=0.6
Uncontrolled (n = 146) 46.7 (1.1) 49.4 (1.0)
Controlled (n = 81) 46.1 (1.2) 48.9 (1.2)
p= 0.7 p=0.7
Note: PCS = physical component score; MCS=mental component score;
SF-36 scores range from zero (worst health) to 100 (best health) and are scaled relative to those of the United States population (mean= 50, standard deviation = 10).
All analyses were adjusted for age, sex, marital status, education, income and rurality.
doi:10.1371/journal.pone.0049921.t004
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in known hypertensives compared to those who had hypertension
but were not aware of it. However, the reductions in PCS and
MCS scores were not significant in this study, possibly due to the
small sample size (including only 104 hypertensive subjects) and
the low response rate (31%). Another study found similar
reductions only in PF and BP [16]. However, in that study the
eligible participants had to have at least one CV risk factor; as a
consequence, HRQoL might already be reduced in normotensive
subjects. Our finding supports previous research linking the
labeling effect of hypertension to psychological well-being [32].
Recent data from the US also showed that individuals labelled as
hypertensive tend to self-report relatively poor health [17,18].
Lastly, in the context of hypertension, our result is concordant with
the well-established result that hypertensives have lower HRQoL
compared to normal subjects [33].
Our study is the first to demonstrate the impact of diabetic
awareness on HRQoL in Asia. Worldwide, there have been
several studies on factors influencing HRQoL in diabetic patients
[34–36], but few report the impact of diabetes screening on
HRQoL [19–21]. Two of these reported a similar SF-36 score
between those unaware that they had diabetes and subjects
without diabetes [19,20]. Another study found that subjects
unaware of their diabetes had a higher anxiety score than subjects
without diabetes, although the SF-36 was not administered in this
study [21]. The high impact of awareness of diabetes on mental
health found in this population might be due to individual’s
perception of the disease. In Thailand, where the standard of
health care service is not yet comparable to that in Western
countries, being labeled with diabetes could easily compromise
mental health, especially in those socioeconomic disadvantaged.
Diabetes itself exerts its detrimental effect on quality of life via
several mechanisms; largely from its complications [34] and
comorbidities [37]. In our analysis, those with established disease
had the lowest physical health score followed by those unaware
and those with no disease, respectively; however, this trend was
not observed in the mental component. Instead, those who were
unaware of diabetes had a marginally better mental health than
those without diabetes (p = 0.08). Possibly this is a chance finding,
although we cannot rule out ‘‘reverse causality’’ whereby, amongst
people with diabetes, those with good mental health are more
likely to seek medical help and thus become diagnosed.
While arthritis exhibited the greatest impact on physical
function and pain, its impact on mental health was less than for
awareness of hypertension. CVD, on the other hand, had a
moderately large impact on both physical and mental health. The
effects of CVD on general health, role limitations, and social
functioning were greatest of all health conditions reported in this
study. This finding confirmed the importance of CVD as a leading
global disease burden. The impact of obesity on physical health
was only secondary to CVD and arthritis, and was larger than
CKD, diabetes or liver disease. Previous studies in the UK [38]
and Sweden [39] also reported decreasing PCS with obesity.
Although obesity showed a positive effect on mental health, this
difference did not reach a statistical significance, and was
consistent with previous research in Asian populations [40–43].
This may be explained by Oriental social and cultural norms,
where moderate overweight is related to wealth and happiness.
The positive effect of exercise on HRQoL was consistent with
findings from a systematic review [44]. Although we cannot
determine whether our association can be explained via a causal
pathway, research has proved the benefits of exercise on health.
Further, exercise, as a lifestyle intervention, has been implemented
into several clinical practice guidelines [45–48]. Here, we extend
knowledge by comparing the effect of exercise to other conditions.
The positive effect of exercise on mental health was comparable in
size to detrimental effects of chronic liver disease, and was larger
than the effects of arthritis, asthma or diabetes. One study showed
that a programme of exercise increased quality of life in diabetic
patients [49]. Whether exercise can attenuate the detrimental
effects of other chronic medical conditions on HRQoL needs
further research. This study has the advantages of a large sample
size and the inclusion of several variables which allowed us to
compare the adjusted effect sizes of multiple health states.
Nevertheless, there are several limitations. First, the healthy
worker effect may apply: those having significant underlying
health problems may not have entered the workforce or
participated in the survey. This may dilute the magnitude of
impacts of poor health on HRQoL, but is less likely to influence
the relative effects of different lifestyle, and other, factors. Second,
details on malignancy and mental illness are lacking in this study.
However, we did cover a large number of other important chronic
conditions. Third, data on awareness, treatment and control was
Figure 2. Effect Sizes* in the presence and absence of self-
reported chronic conditions and lifestyles. A: Effect sizes on
Physical Component Summary (PCS) score. B: Effect sizes on Mental
Component Summary (MCS) score. Footnote: PCS=physical compo-
nent score; MCS =mental component score; HTN = hypertension;
DM=diabetes; Exercise ($3 sessions/week vs ,3/week); obesity
(obesity vs normal); smoker and alcohol (current users vs no); all
diseases are self-reported (yes vs no); awareness (previously diagnosed
vs undiagnosed); For simplicity only presence/absence and treated/
untreated disease categorization and only the most common 5 diseases
are shown; All analyses were adjusted for age, sex, marital status,
education, income and rurality. *Difference in means divided by the
pooled standard deviation.
doi:10.1371/journal.pone.0049921.g002
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only collected for diabetes and hypertension. Forth, measuring
HRQoL by a general health questionnaire might not be as
sensitive to detect a problem as using a disease specific
questionnaire. However in a population context, especially when
we are comparing different diseases, the application of a non-
specific tool is more practical. Finally, this is a cross sectional study
and as such, it is difficult to be certain of the direction of causality.
However, our conclusions about diabetes awareness on HRQoL
are supported by data from randomized controlled trials [21].
In conclusion, despite a different socio-ethnic background, the
impact on HRQoL of several key chronic health states, lifestyle
factors and disease awareness in an urban Thai population were
similar to those previously seen in Western populations. Many of
the chronic conditions studied are common, worldwide, and thus
health promotion is an important part of improving the quality of
life of a population. Being physically active was associated with
better physical and mental health and this is an important part of
such interventions. Awareness of diabetes and hypertension was
associated with impaired mental health, with a magnitude greater
than having the disease itself. This suggests that awareness is an
important consideration when evaluating the cost-benefit of
screening programs and also when employing labels such as pre-
hypertension and pre-diabetes [50]. Further evaluation using
prospective study designs is required to establish causality.
Supporting Information
Appendix S1 Age adjusted mean (with standard error) PCS and
MCS norm-based scores according to socio-demographic and
lifestyle characteristics by sex.
(DOCX)
Appendix S2 Adjusted mean (with Standard Error) SF-36
norm-based scores according to number of chronic condition
and by absence or presence of the 6 most common self-reported
chronic conditions by sex.
(DOCX)
Appendix S3 Percent distribution of comorbidity within top 6
self-reported condition.
(DOCX)
Appendix S4 Adjusted mean (with Standard Error) SF-36
norm-based scores according to severity of hypertension, diabetes,
chronic kidney disease and subgroups of cardiovascular disease, in
those who were aware of their disease.
(DOCX)
Author Contributions
Conceived and designed the experiments: PV PS BH TES HLW MW.
Performed the experiments: PV PS BH. Analyzed the data: PV MK HLW
MW. Contributed reagents/materials/analysis tools: PV PS BH. Wrote the
paper: PV MW TES MK.
References
1. Pais-Ribeiro JL (2004) Quality of life is a primary end-point in clinical settings.
Clin Nutr 23(1): 121–30.
2. Alonso J, Ferrer M, Gandek B, Ware JE Jr, Aaronson NK, et al. (2004) Health-
related quality of life associated with chronic conditions in eight countries: results
from the International Quality of Life Assessment (IQOLA) Project. Quality of
life research: an international journal of quality of life aspects of treatment, care
and rehabilitation 13(2): 283–98.
3. Lyons RA, Lo SV, Littlepage BN (1994) Comparative health status of patients
with 11 common illnesses in Wales. Journal of epidemiology and community
health 48(4): 388–90.
4. Zhang JP, Pozuelo L, Brennan DM, Hoar B, Hoogwerf BJ (2010) Association of
SF-36 with coronary artery disease risk factors and mortality: a PreCIS study.
Preventive cardiology 13(3): 122–9.
5. Shinohara Y (2010) Factors affecting health-related quality of life assessed with
the SF-36v2 health survey in outpatients with chronic-stage ischemic stroke in
Japan–cross-sectional analysis of the OASIS study. Cerebrovasc Dis 29(4): 361–
71.
6. Regensteiner JG, Hiatt WR, Coll JR, Criqui MH, Treat-Jacobson D, et al.
(2008) The impact of peripheral arterial disease on health-related quality of life
in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New
Resources for Survival (PARTNERS) Program. Vasc Med 13(1): 15–24.
7. Soni RK, Weisbord SD, Unruh ML (2010) Health-related quality of life
outcomes in chronic kidney disease. Current opinion in nephrology and
hypertension 19(2): 153–9.
8. Chaiamnuay S, Lomaratana V, Sumransurp S, Phukongchai S, Narongroekna-
win P, et al. (2010) Health-related quality of life and disease severity of SLE
patients in Phramongkutklao Hospital. Journal of the Medical Association of
Thailand 93 Suppl 6: S125–30.
9. Afendy A, Kallman JB, Stepanova M, Younoszai Z, Aquino RD, et al. (2009)
Predictors of health-related quality of life in patients with chronic liver disease.
Alimentary pharmacology & therapeutics 30(5): 469–76.
10. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, et al. (1989)
Functional status and well-being of patients with chronic conditions. Results
from the Medical Outcomes Study. JAMA : the journal of the American Medical
Association 262(7): 907–13.
11. Kempen GI, Ormel J, Brilman EI, Relyveld J (1997) Adaptive responses among
Dutch elderly: the impact of eight chronic medical conditions on health-related
quality of life. American journal of public health 87(1): 38–44.
12. Thommasen HV, Zhang W (2006) Impact of chronic disease on quality of life in
the Bella Coola Valley. Rural and remote health 6(2): 528.
13. Crouchley KD, Alison (2007) Chronic Disease and Quality of Life in Western
Australia. Department of Health, Western Australia 5–8 p.
14. Mena-Martin FJ, Martin-Escudero JC, Simal-Blanco F, Carretero-Ares JL,
Arzua-Mouronte D, et al. (2003) Health-related quality of life of subjects with
known and unknown hypertension: results from the population-based Hortega
study. Journal of hypertension 21(7): 1283–9.
15. Banegas JR, Guallar-Castillon P, Rodriguez-Artalejo F, Graciani A, Lopez-
Garcia E, et al. (2006) Association between awareness, treatment, and control of
hypertension, and quality of life among older adults in Spain. American journal
of hypertension 19(7): 686–93.
16. Korhonen PE, Kivela SL, Kautiainen H, Jarvenpaa S, Kantola I (2011) Health-
related quality of life and awareness of hypertension. Journal of hypertension
29(11): 2070–4.
17. Barger SD, Muldoon MF (2006) Hypertension labelling was associated with
poorer self-rated health in the Third US National Health and Nutrition
Examination Survey. Journal of human hypertension 20(2): 117–23.
18. Hayes DK, Denny CH, Keenan NL, Croft JB, Greenlund KJ (2008) Health-
related quality of life and hypertension status, awareness, treatment, and control:
National Health and Nutrition Examination Survey, 2001–2004. Journal of
hypertension 26(4): 641–7.
19. Eborall HC, Griffin SJ, Prevost AT, Kinmonth AL, French DP, et al. (2007)
Psychological impact of screening for type 2 diabetes: controlled trial and
comparative study embedded in the ADDITION (Cambridge) randomised
controlled trial. BMJ 335(7618): 486.
20. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ (2002) Impact of
diabetes screening on quality of life. Diabetes care 25(6): 1022–6.
21. Park P, Simmons RK, Prevost AT, Griffin SJ (2008) Screening for type 2
diabetes is feasible, acceptable, but associated with increased short-term anxiety:
a randomised controlled trial in British general practice. BMC public health 8:
350.
22. Vathesatogkit P, Woodward M, Tanomsup S, Ratanachaiwong W, Vanavanan
S, et al. (2011) Cohort Profile: The electricity generating authority of Thailand
study. International journal of epidemiology. doi:10.1093/ije/dyq218.
23. Lim LL, Seubsman SA, Sleigh A (2008) Thai SF-36 health survey: tests of data
quality, scaling assumptions, reliability and validity in healthy men and women.
Health and quality of life outcomes 6: 52.
24. Ware JE, Kosinski M, Keller SD (1994) SF-36 Physical and Mental Health
Summary Scales: A User’s Manual. Boston, MA.
25. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003)
The Seventh Report of the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA :
the journal of the American Medical Association 289(19): 2560–72.
26. Third Report of the National Cholesterol Education Program (NCEP) (2003)
Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation
106(25): 3143–421.
27. Walters SJ, Campbell MJ (2004) The use of bootstrap methods for analysing
Health-Related Quality of Life outcomes (particularly the SF-36). Health and
quality of life outcomes 2: 70.
28. Cohen J (1998) Statistical Power Analysis for the Behavioral Sciences. Second
Edition. Hillsdale, New Jersey.
Lifestyle, Disease History and Awareness and HRQoL
PLOS ONE | www.plosone.org 8 November 2012 | Volume 7 | Issue 11 | e49921
29. Krittayaphong R, Bhuripanyo K, Raungratanaamporn O, Chotinaiwatarakul
C, Chaowalit N, et al. (2000) Reliability of Thai version of SF-36 questionnaire
for the evaluation of quality of life in cardiac patients. Journal of the Medical
Association of Thailand 83 Suppl 2: S130–6.
30. Singhpoo K, Tiamkao S, Kuchaisit C, Ariyanuchitkul S, Sangpongsanon S,
et al. (2009) The quality of life of stroke outpatients at Srinagarind Hospital.
Journal of the Medical Association of Thailand 92(12): 1602–9.
31. Tangtrakulwanich B, Wiwatwongwana S, Chongsuvivatwong V, Geater AF
(2006) Comparison of validity, and responsiveness between general and disease-
specific quality of life instruments (Thai version) in knee osteoarthritis. Journal of
the Medical Association of Thailand 89(9): 1454–9.
32. Macdonald LA, Sackett DL, Haynes RB, Taylor DW (1984) Labelling in
hypertension: a review of the behavioural and psychological consequences.
Journal of chronic diseases 37(12): 933–42.
33. Trevisol DJ, Moreira LB, Kerkhoff A, Fuchs SC, Fuchs FD (2011) Health-
related quality of life and hypertension: a systematic review and meta-analysis of
observational studies. Journal of hypertension 29(2): 179–88.
34. Kalda R, Ratsep A, Lember M (2008) Predictors of quality of life of patients with
type 2 diabetes. Patient preference and adherence 2: 21–6.
35. Gulliford MC, Mahabir D (1999) Relationship of health-related quality of life to
symptom severity in diabetes mellitus: a study in Trinidad and Tobago. Journal
of clinical epidemiology 52(8): 773–80.
36. Schram MT, Baan CA, Pouwer F (2009) Depression and quality of life in
patients with diabetes: a systematic review from the European depression in
diabetes (EDID) research consortium. Current diabetes reviews 5(2): 112–9.
37. Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L (1997) Quality of
life and associated characteristics in a large national sample of adults with
diabetes. Diabetes care 20(4): 562–7.
38. Doll HA, Petersen SE, Stewart-Brown SL (2000) Obesity and physical and
emotional well-being: associations between body mass index, chronic illness, and
the physical and mental components of the SF-36 questionnaire. Obesity
research 8(2): 160–70.
39. Larsson U, Karlsson J, Sullivan M (2002) Impact of overweight and obesity on
health-related quality of life–a Swedish population study. International journal
of obesity and related metabolic disorders : journal of the International
Association for the Study of Obesity 26(3): 417–24.
40. Huang IC, Frangakis C, Wu AW (2006) The relationship of excess body weight
and health-related quality of life: evidence from a population study in Taiwan.
Int J Obes (Lond) 30(8): 1250–9.
41. Wee HL, Wu Y, Thumboo J, Lee J, Tai ES (2010) Association of body mass
index with Short-Form 36 physical and mental component summary scores in a
multiethnic Asian population. Int J Obes (Lond) 34(6): 1034–43.
42. HR S, HS P, KE Y (2010) Gender and age differences in the impact of
overweight on obesity-related quality of life among Korean adults. Obes Res
Clin Pract 4(1): e15–e23.
43. Wang R, Wu MJ, Ma XQ, Zhao YF, Yan XY, et al. (2011) Body mass index
and health-related quality of life in adults: a population based study in five cities
of China. European journal of public health 22(4): 497–502
44. Bize R, Johnson JA, Plotnikoff RC (2007) Physical activity level and health-
related quality of life in the general adult population: a systematic review.
Preventive medicine 45(6): 401–15.
45. Fraker TD, Jr., Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, et al. (2007) 2007
chronic angina focused update of the ACC/AHA 2002 guidelines for the
management of patients with chronic stable angina. Journal of the American
College of Cardiology 50(23): 2264–74.
46. National Institute for Health and Clinical Excellence (2010) Prevention of
cardiovascular disease at population level (public health guidance 25).
LONDON: NICE 2010. www.nice.org.uk/guidance/PH25. Accessed 15
October 2012.
47. National Institute for Health and Clinical Excellence (2011) Hypertension:
clinical management of primary hypertension in adults (clinical guideline 127).
LONDON: NICE 2011. www.nice.org.uk/guidance/CG127. Accessed 15
October 2012.
48. National Collaborating Centre for Chronic Conditions (2008) Type 2 diabetes:
national clinical guideline for management in primary and secondary care
(update). London: Royal College of Physicians. http://www.ncbi.nlm.nih.gov/
books/NBK53885/. Accessed 15 October 2012.
49. Ng CL, Tai ES, Goh SY, Wee HL (2011) Health status of older adults with Type
2 diabetes mellitus after aerobic or resistance training: a randomised trial. Health
and quality of life outcomes 9: 59.
50. Zhuo X, Zhang P, Selvin E, Hoerger TJ, Ackermann RT, et al. (2012)
Alternative HbA1c Cutoffs to Identify High-Risk Adults for Diabetes Prevention:
A Cost-Effectiveness Perspective. American Journal of Preventive Medicine
42(4); 374–81.
Lifestyle, Disease History and Awareness and HRQoL
PLOS ONE | www.plosone.org 9 November 2012 | Volume 7 | Issue 11 | e49921
